DSSTox_CID_3472

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

27 API Suppliers, 14 USDMF, 2 CEP/COS, 5 JDMF, 3 EU WC, 2 NDC API, 14 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

79 Dossiers, 29 FDA Orange Book, 8 Europe, 3 Canada, 1 Australia, 25 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 10MG/ML

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 1MG/0.5ML
INJECTABLE;INJECTION - 1MG/0.5ML
INJECTABLE;INJECTION - 10MG/ML

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Roquette, 15 SPI Pharma, 9 Seppic, 8 BASF, 8 Microlex e.U, 8 Gangwal Chemicals, 6 Actylis, 6 Kerry, 5 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Gangwal Healthcare, 3 Ingredion Pharma Solutions, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Sigachi Industries, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Lonza Capsugel, 2 Rochem International Inc, 2 Finar, 2 DKSH, 2 Nanjing Bold Chemical, 1 Aeon Procare, 1 Vasa Pharmachem, 1 Pfanstiehl, 1 Prachin Chemical, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Jai Radhe Sales, 1 Corel Pharma Chem, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 20 Parenteral, 20 Direct Compression, 19 Solubilizers, 13 Chewable & Orodispersible Aids, 13 Taste Masking, 12 Lubricants & Glidants, 10 Topical, 9 Co-Processed Excipients, 8 Empty Capsules, 7 Emulsifying Agents, 7 Coating Systems & Additives, 7 Disintegrants & Superdisintegrants, 7 Granulation, 6 Thickeners and Stabilizers, 6 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Controlled & Modified Release, 3 Surfactant & Foaming Agents, 1 Rheology Modifiers